SMAD2 and central nervous system cancer: In glioma cells, miR-205-5p regulates TGF-β1 by targeting SMAD2, thereby influencing the immune response of TGF-β1 in tumors (Flavell et al., 2010; Meulmeester and Ten Dijke 2011; Duan and Chen 2016).